Fractional COO vs. Full-Time Hire: Making the Right Call for Your Clinical Program

When a biotech company begins to move from discovery into clinical development, the leadership needs change quickly. Someone has to translate a scientific plan into an operational one, manage outside partners, and keep spending aligned with the capital runway. Many founders assume the only answer is a full-time Chief Operating Officer. Often, a fractional COO is the better first step.

Consider the math. A full-time COO with clinical research depth commands a significant salary, equity, benefits, and a recruiting fee. The search itself can take months, during which critical decisions still need to be made. A fractional COO can be in place within weeks and costs a fraction of the fully loaded expense.

Cost is only part of the picture. Stage matters just as much. A pre-IND or Phase 1 company rarely needs forty hours a week of operational leadership. It needs sharp decisions at specific moments: building the clinical development plan, selecting a CRO, negotiating the contract, setting up governance, and preparing the board for what the program will really require. A fractional leader concentrates effort on those moments.

A full-time hire makes more sense when the organization has grown to the point where daily people management, multiple concurrent programs, and cross-functional integration demand constant presence. Even then, many companies use a fractional COO to bridge the gap, stabilize operations, and help define the permanent role so the eventual hire is set up to succeed.

There are a few questions worth asking before deciding. How many active or planned studies do you have in the next 18 months? Is your CRO relationship performing, or do you need someone to reset it? Does your board have confidence in the operational plan? Do you know what the permanent leadership role should look like? If the answers are uncertain, fractional leadership gives you room to learn without locking in a long-term commitment.

The right model also depends on culture. A fractional COO should integrate with your team, attend key meetings, and carry real authority. Treating the role as an outside advisor with no decision rights limits its value.

ABRA Clinical Consulting provides fractional COO and clinical operations leadership for biotech and emerging biopharma sponsors. We help companies make sound operational decisions now while building toward the organization they will need later.